Description

Semax Research Grade Compound Handbook Product Overview

Semax is a synthetic neuropeptide developed by Russia, which exhibits multidimensional neuroprotective and reparative functions by significantly increasing levels of brain-derived neurotrophic factor (BDNF) (↑ 50%) and balancing neurotransmitters such as dopamine and serotonin. Clinical evidence has shown that it can improve neurological recovery after stroke (reducing injury area by 47%), delay cognitive decline (improving memory by 60% in Alzheimer’s model), and effectively alleviate optic neuritis (reducing recurrence rate by 65%) and depressive symptoms (reducing score by 42%). At the same time, this peptide has the potential for synergistic regulation of the nervous and immune systems by inhibiting inflammatory factors (IL-6/TNF – α ↓ 70%) and enhancing immune cell activity (CD8+T cell efficacy ↑ 2.3 times). It has now been expanded to intervention studies for Parkinson’s disease and post-traumatic stress disorder (PTSD)

main features
·   High purity: HPLC verification purity ≥ 99%
·   Research focus: Semax is a synthetic derivative of adrenocorticotropic hormone. Research has shown that it can increase brain-derived neurotrophic factor (BDNF) and may help improve immune function, protect neurons, and cardiovascular function. It may also help control pain and promote blood clotting.
·   Appearance: Peptide in freeze-dried (powder) form
·   Packaging specification: 10mg standard packaging (can be customized according to requirements)
·   Cold chain transportation: Ensure temperature throughout the entire process (-20 ℃)

Disclaimer: The waiver shall ensure that:
Comply with the laboratory’s “Regulations on the Management of Hazardous Chemicals” and local regulations
Established compound lifecycle tracking system
Any consequences resulting from authorized resale or non scientific use shall be borne by the user themselves